Skip to main content
. 2018 Nov 9;14(4):347–355. doi: 10.5114/aic.2018.79194

Table III.

Clinical outcomes at 30 days, 6 months, and 12 months in propensity matched cohort

Parameter BP-SES (n = 672) DP-EES (n = 672) P-value
30 days, n (%):
 TVR 6 (0.9) 8 (1.2) 0.59
 Myocardial infarction 12 (1.8) 16 (2.4) 0.44
 All-cause death 26 (3.9) 17 (2.5) 0.16
6 months, n (%):
 TVR 38 (5.7) 26 (3.9) 0.12
 Myocardial infarction 41 (6.1) 38 (5.7) 0.73
 All-cause death 44 (6.6) 40 (6.0) 0.65
12 months, n (%):
 TVR 48 (7.1) 35 (5.2) 0.14
 Myocardial infarction 56 (8.3) 54 (8.0) 0.84
 All-cause death 57 (8.5) 57 (8.5) 1.00
Definite/probable stent thrombosis, n (%): 17 (2.5) 15 (2.2) 0.72
 Acute (0–1 day) 1 (0.2) 1 (0.2) 1.00
 Subacute (2–30 days) 8 (1.2) 8 (1.2) 1.00
 Late (31–365 days) 8 (1.2) 6 (0.9) 0.59

TVR – target vessel revascularization.